March 28, 2006—Ethicon, Inc, a division of Johnson & Johnson, announced it would recall Panacryl sutures based on concerns that the product was not dissolving in the body as intended. The recall includes 1,061,712 sutures distributed in the United States and worldwide.
Sutures are used in wound healing, and the Panacryl sutures were touted for their strength and absorbability. The Panacryl suture was designed to be absorbed into the patient's body, eliminating the need to remove the device at a later time.
In some patients, the Panacryl suture did not dissolve in the body, leading to infection, granulomas (a bump caused by scar tissue) and other health risks. The problems occur most often in the lower abdominal area and can result in additional surgery and longer recovery times.
Dr. Joel Lippman, former Chief Medical Officer at Ethicon, Inc., reported he was fired in 2006 after objecting to the release of several unsafe products including Panacryl. |